showed that BPC-157 significantly improved recovery following sciatic nerve injuries, with better functional outcomes and nerve regeneration compared to controls [19]
GHK-Cu is a copper binding peptide studied in laboratory settings for its role in cellular signalling, collagen related pathway analysis, and tissue response research
If a patient says they bought it online or heard another clinic offers it, that's your cue to educate, not to consider providing it
Self-administered research peptides from online vendors bypass these safeguards entirely, which is why the risk profile of supervised therapy and unsupervised use are not comparable
In many cases, one pen may support a full cycle when used consistently
I would expect more FDA actions soon